Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight to Discuss Second Quarter 2016 Financial Results on July 28, 2016 Conference Call

Business Wire July 21, 2016

Second Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System

PR Newswire Europe Non Regulatory July 21, 2016

Second Sight Announces CMS Establishes Proposed Medicare Outpatient Rate for Argus II of $150K

Benzinga.com  July 7, 2016

Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering

Business Wire June 1, 2016

Second Sight Files S-1 Registration Statement for Rights Offering to Shareholders and Sets Record Date

Business Wire May 9, 2016

Second Sight Reports First Quarter 2016 Financial Results

Business Wire April 28, 2016

Second Sight to Discuss First Quarter 2016 Financial Results on April 28, 2016 Conference Call

Business Wire April 20, 2016

Second Sight: NHS England Issues Public Policy Consultation on UK Government Funding of the Argus® II Bionic Eye

PR Newswire April 6, 2016

Second Sight Appoints Steven D. Okland Jr. as Commercial Vice President, U.S. and Canada

Business Wire March 24, 2016

Second Sight to Present at the 28th Annual ROTH Conference on March 14, 2016

Business Wire March 7, 2016

Second Sight Reports Fourth Quarter and Year End 2015 Financial Results

Business Wire March 3, 2016

Second Sight to Discuss Fourth Quarter and Year End 2015 Financial Results on March 3, 2016 Conference Call

Business Wire February 29, 2016

Past Winner Spotlight: ENDV, PPCH, EYES, LPCN, GALE

Accesswire February 29, 2016

Second Sight Mourns Loss and Celebrates Legacy of Founder Alfred E. Mann

Business Wire February 26, 2016

These Cheap Stocks Could Be Headed Higher. Here's Why!

Accesswire February 24, 2016

Second Sight to Announce Five-Year Data from Argus II Clinical Trial Program

Business Wire February 23, 2016

Second Sight Announces Publication of Positive Results in 3-Year FLORA Study of the Argus II

Press Releases February 16, 2016

Second Sight to Present at RBC Capital Markets 2016 Global Healthcare Conference and Host Meetings at 2016 BTIG MedTech Conference

Business Wire February 10, 2016

Second Sight Announces Exclusive Agreement with Tecnosalud to Bring the Argus II Retinal Prosthesis to Argentina

Business Wire February 9, 2016

Weird Science: 4 Healthcare And Medical Device Companies Developing Futuristic Technologies In 2016

Accesswire January 29, 2016